Helen Milburn
Keine laufenden Positionen mehr
Ursprung des Netzwerks ersten Grades von Helen Milburn
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
17
| Public Company | Miscellaneous Commercial Services | 17 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Helen Milburn
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| Rochester Christian University | College/University | Undergraduate Degree | |
| FUSION IP PLC | Miscellaneous Commercial Services | Chairman Founder | |
| HVIVO PLC | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| University of Virginia | College/University | Doctorate Degree | |
Novo Holdings AS (Denmark)
 Novo Holdings AS (Denmark) Financial ConglomeratesFinance Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Financial Conglomerates | Corporate Officer/Principal | |
| SURGICAL INNOVATIONS GROUP PLC | Medical Specialties | Chairman | |
| University of Oxford | College/University | Corporate Officer/Principal Doctorate Degree Undergraduate Degree | |
| University of Cambridge | College/University | Corporate Officer/Principal Undergraduate Degree | |
LEO Pharma A/S
 LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ZEALAND PHARMA A/S | Pharmaceuticals: Major | Director/Board Member | |
| University of Sussex | College/University | Graduate Degree | |
PricewaterhouseCoopers LLP (United Kingdom)
 PricewaterhouseCoopers LLP (United Kingdom) Other Consumer ServicesConsumer Services PricewaterhouseCoopers LLP engages in the provision of accounting services. Its services include audit and assurance, accounting advisory, risk assurance, tax management, corporate insolvency, life cycle assessment, forensic services, private equity advisory, and financial reporting valuations. The company is headquartered in London, the United Kingdom. | Other Consumer Services | Corporate Officer/Principal Corporate Officer/Principal | |
| Institut d'Études Politiques d'Aix-en-Provence | College/University | Graduate Degree | |
Touchstone Innovations Investment Management Ltd.
 Touchstone Innovations Investment Management Ltd. Investment ManagersFinance Touchstone Innovations Investment Management Ltd. is a Venture Capital firm, a subsidiary of Touchstone Innovations Ltd. founded in 1986. Touchstone Innovations Investment Management Ltd. is headquartered in London. | Investment Managers | Director/Board Member | |
Fusion IP (Private Equity)
 Fusion IP (Private Equity) Investment ManagersFinance Fusion IP Private Equity (Fusion PE) is the private equity & Venture capital division of Fusion IP plc (LSE: FIP) in the United Kingdom founded in 2002. The firm headquartered in London, Yorkshire. | Investment Managers | Chairman Chief Executive Officer | |
BMI Group Services GmbH
 BMI Group Services GmbH Construction MaterialsNon-Energy Minerals BMI Group Services GmbH provides pitched roofing solutions. Its products include concrete and clay roof tiles, roof accessories, chimney and energy systems, and jacketing. The firm also offers roof expertise services for insulation, solar energy, and ventilation. The company was founded in 1919 and is headquartered in Oberursel, Germany. | Construction Materials | Director/Board Member | |
| XEROS TECHNOLOGY GROUP PLC | Industrial Machinery | Director/Board Member Director/Board Member | |
Fusion Ip Sheffield Ltd.
 Fusion Ip Sheffield Ltd. Miscellaneous Commercial ServicesCommercial Services Part of IP Group Plc, Fusion IP Sheffield Ltd. commercializes intellectual properties. The company is based in London, UK. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| The New School for Social Research | College/University | Undergraduate Degree | |
| NYKODE THERAPEUTICS | Pharmaceuticals: Major | Director/Board Member | |
Novo Seeds
 Novo Seeds Investment ManagersFinance Novo Seeds (Novo Seeds) is a venture capital operating division of Novo Nordisk Fonden. The firm was established in 2007, and is headquartered in Hellerup, Denmark. | Investment Managers | Corporate Officer/Principal | |
| ORPHAZYME A/S | Pharmaceuticals: Major | Corporate Officer/Principal | |
Caerus Consulting AS
 Caerus Consulting AS Pharmaceuticals: MajorHealth Technology Caerus Consulting AS engages in the research and development in biotechnology. It develops antibiotics for life threatening bacterial diseases. Its technological core is chemistry on complex molecules. The company was founded by Torgeir Vaage on March 31, 2009 and is headquartered in Hovik, Norway. | Pharmaceuticals: Major | Director/Board Member | |
Contera Pharma ApS
 Contera Pharma ApS Pharmaceuticals: MajorHealth Technology Contera Pharma ApS is a holding company that identifies and develops treatments for patients suffering from movement disorders. It develops drug candidates based on a combination of repositioning, combinations, and reformulations. The firm's lead project JM-010 is for treatment of dyskinesia associated with Parkinson's disease. It develops an approach of using a combination therapy to tackle clinically relevant synergistic pathways to obtain therapeutic effects which will generate efficacious therapeutic entities based on robust pre-clinical and clinical evidence. The company was founded by Mikael Søndergaard Thomsen and John Bondo Hansen in 2010 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Director/Board Member | |
Autifony Therapeutics Ltd.
 Autifony Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Autifony Therapeutics Ltd. discovers and develops new pharmaceutical treatments treat hearing disorders. The firm focuses on the treatment of hearing disorders, including noise-induced hearing loss and tinnitus. The company was founded by Charles H. Large and Giuseppe S. Alvaro in 2011 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
MISSION Therapeutics Ltd.
 MISSION Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology MISSION Therapeutics Ltd. develops small molecule drugs targeting enzymes involved in cancer and other diseases. It focuses on selectively targeting deubiquitylating enzymes to treat cancer, neurodegenerative and other diseases. The company was founded by Stephen Jackson Philip, Xavier Jacq, Niall M. B. Martin and Keith Menear in 2011 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Acesion Pharma ApS
 Acesion Pharma ApS Pharmaceuticals: MajorHealth Technology Acesion Pharma ApS develops drugs for the treatment of atrial fibrillation (AF), the most common type of cardiac arrhythmia. The firm's technology blocks ion channel with a selective drug molecule constitutes a target for developing treatment of AF. The company was founded by Ulrik Svane S?rensen and Morten Grunnet in 2011 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Director/Board Member | |
IP Group Plc /Venture Capital/
 IP Group Plc /Venture Capital/ Investment ManagersFinance IP Group Plc /Venture Capital/ (IP Group) is a venture capital subsidiary of IP Group Plc founded in 2001. The firm is headquartered in London, United Kingdom. | Investment Managers | Director of Finance/CFO Director/Board Member | |
| Institut d'Administration Des Entreprises De Toulouse | College/University | Undergraduate Degree | |
Avilex Pharma ApS
 Avilex Pharma ApS Pharmaceuticals: MajorHealth Technology Avilex Pharma ApS develops and produces drugs to treat brain damage with the uses of dimeric ligands. It also develops novel inhibitors to target a range of unmet medical needs. The firm uses dimeric ligands that targets intracellular with unprecedented potency. The company was founded by Kristian Strømgaard and Anders Bach on December 27, 2012 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Chairman | |
| Wadham College | College/University | Undergraduate Degree | |
Pulmocide Ltd.
 Pulmocide Ltd. Pharmaceuticals: MajorHealth Technology Pulmocide Ltd. provides biopharmaceutical services. It develops inhaled medicines for viral and fungal infections of the respiratory tract. The company was founded by William Garth Rapeport, John Murray, Kazuhiro Ito, and Peter Strong on March 23, 2007 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| BRAAS MONIER BUILDING GROUP SA | Homebuilding | Director/Board Member | |
| Vivalys Patrimonia Management Sàrl | Corporate Officer/Principal | ||
| Kellogg College | College/University | Masters Business Admin | |
| Maxygen ApS | Corporate Officer/Principal | ||
Enterprise Therapeutics Ltd.
 Enterprise Therapeutics Ltd. BiotechnologyHealth Technology Enterprise Therapeutics Ltd. operates as a drug discovery company that engages in the research and development of therapies for the treatment of respiratory diseases. It focuses on developing therapies for chronic obstructive pulmonary diseases, cystic fibrosis, and asthma. The company was founded by John Mervyn David Store in May 2014 and is headquartered in Falmer, the United Kingdom. | Biotechnology | Director/Board Member | |
| Ayers-Rock Lux SARL | Founder | ||
Oxular Ltd.
 Oxular Ltd. BiotechnologyHealth Technology Oxular Ltd. engages in research and experimental development on biotechnology. The firm develops retinal treatments to access specific small spaces in the eye and to provide drug distribution to tissues involved in retinal diseases. The company was founded by Tom Cavanagh and Ronald K. Yamamoto in 2014 and is headquartered in Oxford, the United Kingdom. | Biotechnology | Director/Board Member | |
STORM Therapeutics Ltd.
 STORM Therapeutics Ltd. BiotechnologyHealth Technology Storm Therapeutics Ltd. develops small molecule drugs that target RNA-modifying enzymes. It offers research and development of drug molecules for the treatment of specific cancers. The company was founded by Anthony Kouzarides and Eric Miska on April 21, 2015 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Director/Board Member | |
Artios Pharma Ltd.
 Artios Pharma Ltd. Pharmaceuticals: MajorHealth Technology Artios Pharma Ltd. manufactures pharmaceutical products. The firm develops a DNA Damage Response (DDR) is a cancer therapy. The company was founded by Niall Martin in May 2016 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| Northzone Ventures UK Ltd. | Investment Managers | Director of Finance/CFO | |
Uniphy Ltd.
 Uniphy Ltd. Electronic Production EquipmentElectronic Technology Uniphy Ltd. operates as an optical touch interface firm. Its application includes smart home, white goods, and automotive. The company was founded by David Lomas and David Dearn and is headquartered in Swindon, the United Kingdom. | Electronic Production Equipment | Director/Board Member | |
| HVIVO PLC | Miscellaneous Commercial Services | Director/Board Member | |
| Curadh Pharmaceuticals Ltd. | Chief Executive Officer | ||
Keltic Pharma Therapeutics Ltd.
 Keltic Pharma Therapeutics Ltd. BiotechnologyHealth Technology Keltic Pharma Therapeutics Ltd. is an Irish private company. The firm engages in drug discovery programs. | Biotechnology | Chief Executive Officer | |
| IP Venture Fund (GP) Ltd. | Director/Board Member Director/Board Member |
Statistik
International
| Vereinigtes Königreich | 28 |
| Dänemark | 12 |
| Vereinigte Staaten | 4 |
| Luxemburg | 4 |
| Frankreich | 3 |
Sektoral
| Health Technology | 21 |
| Consumer Services | 12 |
| Finance | 7 |
| Commercial Services | 5 |
| Non-Energy Minerals | 2 |
Operativ
| Director/Board Member | 87 |
| Corporate Officer/Principal | 24 |
| Undergraduate Degree | 17 |
| Chairman | 14 |
| Independent Dir/Board Member | 12 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Helen Milburn
- Unternehmensverbindungen
